skip to main | skip to sidebar

Intellectual Property Rights

Sunday, May 6, 2007

GENERIC DRUG ENTRY

Pharmaceutical drug products havebecome increasingly important to providingconsumers with a myriad of treatments andcures that increase life expectancy andenhance lives. It is critical to maintainappropriate incentives for the developmentof new drug products, because the necessaryresearch and development is risky andcostly. Innovation in the pharmaceuticalindustry, spurred in part by competitivemarket forces, continues to bring enormousbenefits to Americans.


http://www.ftc.gov/os/2002/07/genericdrugstudy.pdf
Posted by CLINICAL RESEARCH at 11:23 PM

No comments:

Post a Comment

Older Post Home
Subscribe to: Post Comments (Atom)

Blog Archive

  • ▼  2007 (3)
    • ▼  May (2)
      • GENERIC DRUG ENTRY
      • INDIAN PHARMACEUTICAL INDUSTRY
    • ►  April (1)

About Me

CLINICAL RESEARCH
View my complete profile